• Profile
Close

Clinical significance of ‘double-hit’ and ‘double-expression’ lymphomas

Journal of Clinical Pathology Feb 26, 2020

Ma1 Z, Niu1 J, Cao Y, et al. - The research was sought to ascertain the frequency of ‘Double-hit’ lymphoma (DHL) and ‘double-expression’ lymphoma (DEL) in diffuse large B-cell lymphoma (DLBCL) and their prognostic impacts in the era of cyclophosphamide, doxorubicin, vincristine, and prednisone plus rituximab therapy. In this study, the data and tissues from 98 patients diagnosed with DLBCL were applied. They assembled formalin-fixed and paraffin-embedded tissues for immunohistochemistry (IHC) and interphase fluorescence in situ hybridization (FISH) analysis for MYC, BCL6, and BCL2 rearrangements. The study found that MYC/BCL2 DHL, MYC/BCL6 DHL, and MYC/BCL2 DEL are aggressive B cell lymphoma and individuals have a poor prognosis. For DHL and DEL, IPI and bone marrow involvement were independent prognostic factors. for survival, BCL2, BCL6 and MYC rearrangements translocation, expression concurrent rearrangements and coexpression were independent prognostic factors.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay